These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12032401)

  • 1. Rational use of the PFA-100 device for screening of platelet function disorders and von Willebrand disease.
    Buyukasik Y; Karakus S; Goker H; Haznedaroglu IC; Ozatli D; Sayinalp N; Ozcebe OI; Dundar SV; Kirazli S
    Blood Coagul Fibrinolysis; 2002 Jun; 13(4):349-53. PubMed ID: 12032401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PFA-100 system: a new method for assessment of platelet dysfunction.
    Mammen EF; Comp PC; Gosselin R; Greenberg C; Hoots WK; Kessler CM; Larkin EC; Liles D; Nugent DJ
    Semin Thromb Hemost; 1998; 24(2):195-202. PubMed ID: 9579642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a novel platelet function analyzer (PFA-100) with high sensitivity to disturbances in von Willebrand factor to screen for von Willebrand's disease and other disorders.
    Favaloro EJ; Facey D; Henniker A
    Am J Hematol; 1999 Nov; 62(3):165-74. PubMed ID: 10539883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The PFA-100: a potential rapid screening tool for the assessment of platelet dysfunction.
    Harrison P; Robinson M; Liesner R; Khair K; Cohen H; Mackie I; Machin S
    Clin Lab Haematol; 2002 Aug; 24(4):225-32. PubMed ID: 12181026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of PFA-100 closure time and template bleeding time of patients with inherited disorders causing defective platelet function.
    Kerényi A; Schlammadinger A; Ajzner E; Szegedi I; Kiss C; Pap Z; Boda Z; Muszbek L
    Thromb Res; 1999 Dec; 96(6):487-92. PubMed ID: 10632473
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of PFA-100 testing and bleeding time for detecting platelet hypofunction and von Willebrand disease in clinical practice.
    Posan E; McBane RD; Grill DE; Motsko CL; Nichols WL
    Thromb Haemost; 2003 Sep; 90(3):483-90. PubMed ID: 12958618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. External quality assessment/proficiency testing and internal quality control for the PFA-100 and PFA-200: an update.
    Favaloro EJ; Bonar R
    Semin Thromb Hemost; 2014 Mar; 40(2):239-53. PubMed ID: 24497116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the O'Brien filter test and the PFA-100 platelet analyzer in the laboratory diagnosis of von Willebrand's disease.
    Schlammadinger A; Kerenyi A; Muszbek L; Boda Z
    Thromb Haemost; 2000 Jul; 84(1):88-92. PubMed ID: 10928476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.
    Dean JA; Blanchette VS; Carcao MD; Stain AM; Sparling CR; Siekmann J; Turecek PL; Lillicrap D; Rand ML
    Thromb Haemost; 2000 Sep; 84(3):401-9. PubMed ID: 11019962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the platelet function analyser (PFA-100) in the characterization of patients with von Willebrand's disease and its relationships with von Willebrand factor and the ABO blood group.
    Nitu-Whalley IC; Lee CA; Brown SA; Riddell A; Hermans C
    Haemophilia; 2003 May; 9(3):298-302. PubMed ID: 12694521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of the platelet function analyser (PFA-100/200) for exclusion or detection of von Willebrand disease: A study 22 years in the making.
    Favaloro EJ
    Thromb Res; 2020 Apr; 188():17-24. PubMed ID: 32036157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2.
    van Vliet HH; Kappers-Klunne MC; Leebeek FW; Michiels JJ
    Thromb Haemost; 2008 Sep; 100(3):462-8. PubMed ID: 18766263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of platelet function analyzer as a screening tool for the diagnosis of von Willebrand disease in adolescents with menorrhagia.
    Naik S; Teruya J; Dietrich JE; Jariwala P; Soundar E; Venkateswaran L
    Pediatr Blood Cancer; 2013 Jul; 60(7):1184-7. PubMed ID: 23335259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the new INNOVANCE® PFA P2Y cartridge in patients with impaired primary haemostasis.
    Koessler J; Ehrenschwender M; Kobsar A; Brunner K
    Platelets; 2012; 23(8):571-8. PubMed ID: 22185369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of primary hemostasis by PFA-100 analysis in a tertiary care center.
    Ortel TL; James AH; Thames EH; Moore KD; Greenberg CS
    Thromb Haemost; 2000 Jul; 84(1):93-7. PubMed ID: 10928477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The utility of the PFA-100 in the identification of von Willebrand disease: a concise review.
    Favaloro EJ
    Semin Thromb Hemost; 2006 Jul; 32(5):537-45. PubMed ID: 16862528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variables influencing Platelet Function Analyzer-100 closure times in healthy individuals.
    Haubelt H; Anders C; Vogt A; Hoerdt P; Seyfert UT; Hellstern P
    Br J Haematol; 2005 Sep; 130(5):759-67. PubMed ID: 16115134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of aspirin treatment in patients with peripheral arterial disease monitored with the platelet function analyzer PFA-100.
    Roller RE; Dorr A; Ulrich S; Pilger E
    Blood Coagul Fibrinolysis; 2002 Jun; 13(4):277-81. PubMed ID: 12032391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High resolution multimer analysis and the PFA-100 platelet function analyser can detect von Willebrand disease type 2A without a pathological ratio of ristocetin cofactor activity and von Willebrand antigen level.
    Weiss DR; Strasser EF; Ringwald J; Zimmermann R; Eckstein R
    Clin Lab; 2012; 58(11-12):1203-9. PubMed ID: 23289190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [High-shear force-induced platelet aggregation in the screening and diagnosis of von Willebrand disease].
    Schlammadinger A; Kerényi A; Muszbek L; Boda Z
    Orv Hetil; 2000 Oct; 141(41):2245-50. PubMed ID: 11184249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.